ADMA Biologics, Inc. (ADMA)
USD 23.52
(1.07%)
USD 23.52
(1.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 141.41 Million USD | -8.43% |
| 2022 | 154.44 Million USD | 50.06% |
| 2021 | 102.91 Million USD | 5.38% |
| 2020 | 97.66 Million USD | 15.27% |
| 2019 | 84.73 Million USD | 91.59% |
| 2018 | 44.22 Million USD | 2.92% |
| 2017 | 42.97 Million USD | 112.11% |
| 2016 | 20.25 Million USD | 28.79% |
| 2015 | 15.73 Million USD | 5.08% |
| 2014 | 14.97 Million USD | 194.94% |
| 2013 | 5.07 Million USD | 27.88% |
| 2012 | 3.96 Million USD | -59.57% |
| 2011 | 9.81 Million USD | 36.36% |
| 2010 | 7.2 Million USD | -37.43% |
| 2009 | 11.5 Million USD | -27.89% |
| 2008 | 15.95 Million USD | 58.44% |
| 2007 | 10.07 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 141.42 Million USD | 0.01% |
| 2024 Q2 | 141.39 Million USD | -0.02% |
| 2023 Q2 | 151.51 Million USD | -2.7% |
| 2023 Q3 | 152.97 Million USD | 0.96% |
| 2023 Q1 | 155.72 Million USD | 0.83% |
| 2023 FY | 141.41 Million USD | -8.43% |
| 2023 Q4 | 141.41 Million USD | -7.55% |
| 2022 Q1 | 146.36 Million USD | 42.21% |
| 2022 Q3 | 152.72 Million USD | 0.97% |
| 2022 FY | 154.44 Million USD | 50.06% |
| 2022 Q4 | 154.44 Million USD | 1.13% |
| 2022 Q2 | 151.26 Million USD | 3.35% |
| 2021 Q4 | 102.91 Million USD | 1.12% |
| 2021 FY | 102.91 Million USD | 5.38% |
| 2021 Q1 | 100.15 Million USD | 2.54% |
| 2021 Q2 | 101.33 Million USD | 1.18% |
| 2021 Q3 | 101.77 Million USD | 0.44% |
| 2020 Q3 | 100.18 Million USD | 0.46% |
| 2020 Q2 | 99.72 Million USD | 1.6% |
| 2020 Q1 | 98.15 Million USD | 15.84% |
| 2020 FY | 97.66 Million USD | 15.27% |
| 2020 Q4 | 97.66 Million USD | -2.51% |
| 2019 Q2 | 83.99 Million USD | 46.24% |
| 2019 Q4 | 84.73 Million USD | 0.48% |
| 2019 FY | 84.73 Million USD | 91.59% |
| 2019 Q1 | 57.43 Million USD | 29.88% |
| 2019 Q3 | 84.32 Million USD | 0.39% |
| 2018 Q2 | 43.65 Million USD | 1.0% |
| 2018 FY | 44.22 Million USD | 2.92% |
| 2018 Q4 | 44.22 Million USD | 0.66% |
| 2018 Q1 | 43.22 Million USD | 0.6% |
| 2018 Q3 | 43.93 Million USD | 0.63% |
| 2017 Q4 | 42.97 Million USD | 37.91% |
| 2017 Q3 | 31.15 Million USD | -4.55% |
| 2017 Q2 | 32.64 Million USD | 68.84% |
| 2017 Q1 | 19.33 Million USD | -4.57% |
| 2017 FY | 42.97 Million USD | 112.11% |
| 2016 Q3 | 20.06 Million USD | 0.93% |
| 2016 Q1 | 15.86 Million USD | 0.83% |
| 2016 Q2 | 19.88 Million USD | 25.37% |
| 2016 Q4 | 20.25 Million USD | 0.95% |
| 2016 FY | 20.25 Million USD | 28.79% |
| 2015 Q3 | 15.6 Million USD | 0.77% |
| 2015 Q1 | 15.08 Million USD | 0.78% |
| 2015 Q2 | 15.48 Million USD | 2.63% |
| 2015 FY | 15.73 Million USD | 5.08% |
| 2015 Q4 | 15.73 Million USD | 0.82% |
| 2014 Q2 | 9.91 Million USD | 0.3% |
| 2014 Q4 | 14.97 Million USD | 48.79% |
| 2014 Q3 | 10.06 Million USD | 1.52% |
| 2014 FY | 14.97 Million USD | 194.94% |
| 2014 Q1 | 9.88 Million USD | 94.69% |
| 2013 Q1 | 5.01 Million USD | 26.31% |
| 2013 Q3 | 5.05 Million USD | 0.42% |
| 2013 Q4 | 5.07 Million USD | 0.43% |
| 2013 FY | 5.07 Million USD | 27.88% |
| 2013 Q2 | 5.03 Million USD | 0.4% |
| 2012 Q2 | 93.98 Thousand USD | -2.73% |
| 2012 FY | 3.96 Million USD | -59.57% |
| 2012 Q4 | 3.96 Million USD | 4247.76% |
| 2012 Q3 | 91.28 Thousand USD | -2.87% |
| 2012 Q1 | 96.61 Thousand USD | 0.0% |
| 2011 Q1 | 5.81 Million USD | 20.76% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | 9.81 Million USD | 36.36% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q2 | 9.81 Million USD | 68.75% |
| 2010 Q2 | 12.35 Million USD | 84.23% |
| 2010 Q4 | 4.81 Million USD | -44.03% |
| 2010 Q3 | 8.6 Million USD | -30.34% |
| 2010 Q1 | 6.7 Million USD | 15.5% |
| 2010 FY | 7.2 Million USD | -37.43% |
| 2009 Q2 | 11.5 Million USD | 67.8% |
| 2009 FY | 11.5 Million USD | -27.89% |
| 2009 Q4 | 5.8 Million USD | -41.38% |
| 2009 Q3 | 9.9 Million USD | -13.9% |
| 2009 Q1 | 6.85 Million USD | -8.05% |
| 2008 Q4 | 7.45 Million USD | 0.0% |
| 2008 Q1 | 11.05 Million USD | 31.5% |
| 2008 FY | 15.95 Million USD | 58.44% |
| 2008 Q2 | 15.95 Million USD | 44.31% |
| 2007 Q4 | 8.4 Million USD | -1.16% |
| 2007 Q1 | 3.57 Million USD | -7.6% |
| 2007 Q2 | 10.07 Million USD | 181.97% |
| 2007 FY | 10.07 Million USD | 0.0% |
| 2007 Q3 | 8.5 Million USD | -15.53% |
| 2006 Q4 | 3.86 Million USD | 6.91% |
| 2006 Q3 | 3.61 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -99490.141% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1746.816% |
| XOMA Corporation | 124.45 Million USD | -13.634% |
| Mesoblast Limited | 118.92 Million USD | -18.916% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 38.297% |
| Aptorum Group Limited | 3.36 Million USD | -4105.869% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -10784.872% |
| HilleVax, Inc. | 51.19 Million USD | -176.245% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -464.723% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -577.152% |
| Precision BioSciences, Inc. | 31.26 Million USD | -352.277% |
| Dyadic International, Inc. | 136.92 Thousand USD | -103178.341% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -89405.063% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -4824.025% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -2492.447% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -65983.178% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -2485.811% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 38.362% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1038.265% |
| IGM Biosciences, Inc. | 40.5 Million USD | -249.129% |
| Opthea Limited | 200.62 Million USD | 29.513% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -173.14% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -2518.852% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1341.129% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -2193.885% |
| NextCure, Inc. | 6.6 Million USD | -2041.075% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -22635.903% |
| Ovid Therapeutics Inc. | 46 Million USD | -207.419% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -565.841% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -368.024% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -127.818% |
| Senti Biosciences, Inc. | 37.66 Million USD | -275.453% |
| Apollomics, Inc. | 4.66 Million USD | -2934.07% |
| PureTech Health plc | 25.51 Million USD | -454.32% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -44371.069% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -989.843% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -67.015% |
| ChromaDex Corporation | 3.27 Million USD | -4215.471% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -35.741% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -271.137% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -34.973% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -36.588% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -39.487% |
| Fortress Biotech, Inc. | 88.59 Million USD | -59.628% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -123.88% |
| Celcuity Inc. | 37.44 Million USD | -277.656% |
| ContextLogic Inc. | 6 Million USD | -2256.967% |
| GH Research PLC | 343 Thousand USD | -41129.738% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2056.091% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -382110.811% |
| ImmuCell Corporation | 11.96 Million USD | -1081.506% |
| Amarin Corporation plc | 8.73 Million USD | -1518.611% |
| TG Therapeutics, Inc. | 110.79 Million USD | -27.639% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -142.649% |
| Acelyrin, Inc. | 1.19 Million USD | -11744.054% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -400.435% |
| Novavax, Inc. | 280.63 Million USD | 49.608% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -1.718% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 97.56% |
| AnaptysBio, Inc. | 17.81 Million USD | -693.859% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2520.308% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -964.414% |
| AbCellera Biologics Inc. | 77.38 Million USD | -82.758% |
| CorMedix Inc. | 667.63 Thousand USD | -21082.028% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1190.899% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 94.768% |
| Aptose Biosciences Inc. | 1 Million USD | -13904.472% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1633656.932% |
| Soligenix, Inc. | 3.49 Million USD | -3946.803% |
| Century Therapeutics, Inc. | 48.17 Million USD | -193.575% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -22.79% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -31286.396% |
| Kura Oncology, Inc. | 17.2 Million USD | -722.198% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1947.756% |
| Ardelyx, Inc. | 55.98 Million USD | -152.613% |
| Ainos, Inc. | 5.96 Million USD | -2271.37% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -52.995% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -6477.581% |
| Prothena Corporation plc | 11.83 Million USD | -1094.913% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -912.008% |
| Autolus Therapeutics plc | 52.96 Million USD | -166.993% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -460.404% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -237.973% |
| Celularity Inc. | 65.41 Million USD | -116.179% |
| Rallybio Corporation | 392 Thousand USD | -35976.02% |
| GRI Bio, Inc. | 14 Thousand USD | -1010028.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 58.195% |
| INmune Bio, Inc. | 10.43 Million USD | -1254.968% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 21.272% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2294.051% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -173036.631% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -17003.347% |
| Humacyte, Inc. | 58.1 Million USD | -143.379% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -144.363% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 70.59% |
| Immunocore Holdings plc | 84.03 Million USD | -68.291% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -7531.84% |
| Verastem, Inc. | 41.55 Million USD | -240.299% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1143.563% |
| Histogen Inc. | 4.62 Million USD | -2959.671% |
| Surrozen, Inc. | 3.37 Million USD | -4085.203% |
| Blueprint Medicines Corporation | 774.12 Million USD | 81.732% |
| Organovo Holdings, Inc. | 1.39 Million USD | -10044.763% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -5570.329% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -243724.138% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -67.184% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -67557.64% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -2718.214% |
| Summit Therapeutics Inc. | 106.09 Million USD | -33.289% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -28.145% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -87024.577% |
| Turnstone Biologics Corp. | 3.21 Million USD | -4300.062% |
| Pulmatrix, Inc. | 8.75 Million USD | -1515.098% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -57154.251% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -44.885% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -921.069% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -22.603% |
| Cytokinetics, Incorporated | 755.77 Million USD | 81.288% |
| Exelixis, Inc. | 189.94 Million USD | 25.548% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -361.939% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -27.486% |
| Evogene Ltd. | 1.13 Million USD | -12326.889% |
| Replimune Group, Inc. | 75.86 Million USD | -86.398% |
| PDS Biotechnology Corporation | 23.85 Million USD | -492.907% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -256254.573% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4976.023% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -175950.692% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -289275.895% |
| BioLineRx Ltd. | 11.59 Million USD | -1120.067% |
| Avid Bioservices, Inc. | 207.83 Million USD | 31.956% |
| Insmed Incorporated | 1.2 Billion USD | 88.254% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -6570.66% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -208.955% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -217466.154% |
| MediWound Ltd. | 6.71 Million USD | -2007.257% |
| MiMedx Group, Inc. | 48.09 Million USD | -194.014% |
| OmniAb, Inc. | 25.56 Million USD | -453.257% |
| Alector, Inc. | 38.91 Million USD | -263.374% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 33.897% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 65.926% |
| Mereo BioPharma Group plc | 5.95 Million USD | -2275.974% |
| Zai Lab Limited | 15.15 Million USD | -833.391% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 70.441% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -8549.419% |
| Aura Biosciences, Inc. | 19.55 Million USD | -623.107% |
| Immunic, Inc. | 1.33 Million USD | -10501.049% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -415.842% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -345.664% |
| Veracyte, Inc. | 12.63 Million USD | -1019.699% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 78.07% |
| FibroGen, Inc. | 170.45 Million USD | 17.035% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1457.295% |
| Allakos Inc. | 41.46 Million USD | -241.054% |
| scPharmaceuticals Inc. | 40.26 Million USD | -251.183% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1206.885% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -93554.305% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -8556.058% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -69252.806% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -3237.692% |
| Precigen, Inc. | 7.09 Million USD | -1892.645% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 91.572% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1832.732% |
| Incyte Corporation | 38.28 Million USD | -269.363% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -46927.408% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -227.607% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1169.689% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4976.023% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 40.738% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -443.017% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -40420.917% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -426.089% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -213.753% |
| Agenus Inc. | 350.24 Million USD | 59.623% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -132201.129% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -9866.032% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -212.623% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -227.592% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -193.222% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -86147.843% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 83.337% |
| UroGen Pharma Ltd. | 100.21 Million USD | -41.116% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -13664.675% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 22.616% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -996222.39% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -46266.557% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -35975.836% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1969.027% |
| Chimerix, Inc. | 2.14 Million USD | -6495.989% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -14434.224% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -297.741% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -81799.313% |
| Pluri Inc. | 29.61 Million USD | -377.57% |
| Cue Biopharma, Inc. | 14.69 Million USD | -862.355% |
| MeiraGTx Holdings plc | 89.26 Million USD | -58.427% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -662279.391% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -2799.692% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -128.765% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -35.853% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1944.499% |
| NLS Pharmaceutics AG | 1.63 Million USD | -8556.058% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -348.263% |
| Nutriband Inc. | 241.28 Thousand USD | -58510.357% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -2486.757% |
| Vor Biopharma Inc. | 35.66 Million USD | -296.573% |
| Roivant Sciences Ltd. | 499.74 Million USD | 71.702% |
| ProKidney Corp. | 4.41 Million USD | -3104.577% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -11434.91% |
| Daré Bioscience, Inc. | 5.31 Million USD | -2559.16% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 91.872% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -24929.735% |
| Bicycle Therapeutics plc | 44.95 Million USD | -214.57% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -263.356% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -96.942% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -60.805% |
| Atai Life Sciences N.V. | 16.47 Million USD | -758.327% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -5669.818% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -20850.815% |
| MediciNova, Inc. | 215.92 Thousand USD | -65393.734% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -5568.056% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -11114.501% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -12294.216% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 24.121% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1273.524% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -153.17% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -3839.22% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1443.696% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -863.929% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1053.679% |
| bluebird bio, Inc. | 330.32 Million USD | 57.188% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1030.801% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -8604.178% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 87.528% |
| BioAtla, Inc. | 2.46 Million USD | -5648.699% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -48.672% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -2449.91% |
| DBV Technologies S.A. | 14.38 Million USD | -883.367% |
| Fortress Biotech, Inc. | 88.59 Million USD | -59.628% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1335.424% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -646.939% |
| aTyr Pharma, Inc. | 15.09 Million USD | -836.853% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -571.883% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -43214.252% |
| Galecto, Inc. | 249 Thousand USD | -56694.378% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -8566.779% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 90.567% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -33.333% |
| Entera Bio Ltd. | 390 Thousand USD | -36161.026% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 65.063% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -2177.996% |
| Xencor, Inc. | 83.43 Million USD | -69.497% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -8282.81% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2968.301% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -11451.625% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1403.807% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -86147.843% |
| Portage Biotech Inc. | 47 Thousand USD | -300789.362% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -11114.501% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -5750.972% |
| OncoCyte Corporation | 2.86 Million USD | -4829.174% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -93831.745% |
| Purple Biotech Ltd. | 351 Thousand USD | -40190.028% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -4376.67% |
| Onconetix, Inc. | 9.88 Million USD | -1330.521% |
| MacroGenics, Inc. | 33.97 Million USD | -316.29% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -6852.707% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -2603.46% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -937.321% |
| Aditxt, Inc. | 18.21 Million USD | -676.255% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -428.903% |
| Curis, Inc. | 2.79 Million USD | -4961.489% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -6519.301% |
| Adagene Inc. | 22.3 Million USD | -533.966% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -745.245% |
| BeiGene, Ltd. | 930.18 Million USD | 84.797% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 32.703% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -17393.524% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 76.853% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -185976.316% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -5552.198% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -72.426% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 31.322% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2945.177% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 94.728% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -133.444% |
| Clene Inc. | 32.16 Million USD | -339.719% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -5463.257% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -650.109% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -6342.733% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -179.085% |
| Adicet Bio, Inc. | 20.92 Million USD | -575.865% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 26.799% |
| Absci Corporation | 15.95 Million USD | -786.244% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -824.119% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -596.881% |
| Surrozen, Inc. | 3.37 Million USD | -4085.203% |
| Generation Bio Co. | 97.89 Million USD | -44.46% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -42884.195% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -414.528% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -459.009% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -476.229% |
| Invivyd, Inc. | 2.16 Million USD | -6432.009% |
| Cingulate Inc. | 3.13 Million USD | -4410.799% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -164.501% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -4013204.084% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -28132.612% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -2451.29% |
| Jaguar Health, Inc. | 35.86 Million USD | -294.361% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -224373.016% |
| 2seventy bio, Inc. | 256.67 Million USD | 44.903% |
| Clearside Biomedical, Inc. | 43 Million USD | -228.871% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -23352.405% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -147.213% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -2419.852% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -29285.864% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -400.205% |
| Innoviva, Inc. | 449.07 Million USD | 68.509% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -599.431% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -107.267% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -722.341% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -13.552% |
| Evaxion Biotech A/S | 10.86 Million USD | -1201.032% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -69.588% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -88.791% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2077.001% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -344821.951% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -423.964% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -30312.473% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -415.578% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1284.686% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -3875.766% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -8994.405% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -11123.651% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -879.078% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -15509.051% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -173.388% |
| ImmunityBio, Inc. | 883.67 Million USD | 83.997% |
| Korro Bio, Inc. | 33.2 Million USD | -325.868% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -99.248% |
| Kineta, Inc. | 1.31 Million USD | -10637.889% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -60213.642% |
| BioVie Inc. | 6.11 Million USD | -2213.986% |
| Codexis, Inc. | 22.36 Million USD | -532.347% |
| Celularity Inc. | 65.41 Million USD | -116.179% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -36823.76% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -62948.596% |
| Kodiak Sciences Inc. | 181.63 Million USD | 22.14% |
| Cibus, Inc. | 24.62 Million USD | -474.38% |
| Annexon, Inc. | 31.35 Million USD | -351.022% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -5938.343% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 90.271% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -88.467% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -3523.315% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -777.95% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -26.844% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -207.17% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -340.308% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -14257.157% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1134.337% |
| Alkermes plc | 290.73 Million USD | 51.358% |
| Arcellx, Inc. | 97.62 Million USD | -44.858% |
| Moolec Science SA | 2.64 Million USD | -5246.032% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -6480.642% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2140.108% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -433.391% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -4458.93% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -5787.51% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -8060.3% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -143.379% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -396.43% |
| Geron Corporation | 85.89 Million USD | -64.633% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -210.74% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 97.695% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -122601.164% |
| Notable Labs, Ltd. | 2.04 Million USD | -6801.806% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -318.025% |
| Structure Therapeutics Inc. | 5.45 Million USD | -2493.398% |
| IN8bio, Inc. | 4.89 Million USD | -2790.211% |
| 89bio, Inc. | 27.1 Million USD | -421.684% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -35254.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -163.309% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -5514.053% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -10469.357% |
| Liquidia Corporation | 3.5 Million USD | -3937.054% |
| Mustang Bio, Inc. | 2.49 Million USD | -5561.249% |
| Immunovant, Inc. | 138 Thousand USD | -102376.812% |
| Vericel Corporation | 88.14 Million USD | -60.442% |
| Quantum-Si incorporated | 15.3 Million USD | -824.119% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1521.58% |
| XOMA Corporation | 124.45 Million USD | -13.634% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -51512.409% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -173036.631% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -965.215% |
| Vaxcyte, Inc. | 29.22 Million USD | -383.91% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1197.056% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -69564.039% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -584.468% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -8455.233% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -11123.651% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -34991.315% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -13603.295% |
| PepGen Inc. | 20.1 Million USD | -603.432% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -24537.282% |
| United Therapeutics Corporation | 700 Million USD | 79.797% |
| Solid Biosciences Inc. | 26.26 Million USD | -438.428% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -14257.157% |
| Immuneering Corporation | 4.46 Million USD | -3068.705% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -139917.822% |
| Belite Bio, Inc | 886 Thousand USD | -15861.4% |
| Pharming Group N.V. | 171.54 Million USD | 17.562% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 40.982% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -562.969% |
| uniQure N.V. | 138.4 Million USD | -2.174% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -740.273% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -65.55% |
| Altimmune, Inc. | 671 Thousand USD | -20975.708% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -965.215% |
| Peak Bio, Inc. | 10.72 Million USD | -1218.975% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1457.295% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -7994.906% |
| Benitec Biopharma Inc. | 284 Thousand USD | -49695.07% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 68.225% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -48724.933% |
| Compugen Ltd. | 1.35 Million USD | -10367.654% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -67085.459% |
| argenx SE | 20 Million USD | -607.09% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -230.679% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -67.25% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -609.894% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -20.671% |
| PolyPid Ltd. | 11.77 Million USD | -1100.594% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -54.626% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -3282.397% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -24074.017% |
| Instil Bio, Inc. | 86.05 Million USD | -64.336% |
| Elevation Oncology, Inc. | 30.13 Million USD | -369.25% |
| Immunome, Inc. | 1.65 Million USD | -8470.788% |
| Verona Pharma plc | 51.32 Million USD | -175.513% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1346.288% |
| Shattuck Labs, Inc. | 4.2 Million USD | -3265.493% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -38965.746% |
| Design Therapeutics, Inc. | 3.05 Million USD | -4536.656% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -53876.336% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -893.942% |
| Achilles Therapeutics plc | 4.61 Million USD | -2964.312% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 62.159% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -369.843% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -3724.314% |
| Beam Therapeutics Inc. | 173.17 Million USD | 18.337% |
| Moolec Science SA | 2.64 Million USD | -5246.032% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -29672.211% |
| AEON Biopharma, Inc. | 278 Thousand USD | -50769.784% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1913.354% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -42114.328% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -86.415% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -131.427% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -368.128% |
| Athira Pharma, Inc. | 1.58 Million USD | -8822.271% |
| HCW Biologics Inc. | 6.45 Million USD | -2091.923% |
| XOMA Corporation | 124.45 Million USD | -13.634% |
| NeurAxis, Inc. | 224.26 Thousand USD | -62959.841% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2047.578% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1346.288% |
| 180 Life Sciences Corp. | 1.32 Million USD | -10612.925% |
| Nektar Therapeutics | 230.4 Million USD | 38.621% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -609.894% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -727.968% |
| Arvinas, Inc. | 3.4 Million USD | -4059.353% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -8994.405% |
| Palisade Bio, Inc. | 369 Thousand USD | -38224.661% |
| Nutriband Inc. | 241.28 Thousand USD | -58510.357% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -8566.779% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -17020.823% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -33976.627% |
| Merus N.V. | 12.16 Million USD | -1062.786% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -10.115% |
| Neurogene Inc. | 16.25 Million USD | -769.997% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 54.106% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -395.491% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -923.73% |
| Rezolute, Inc. | 2.22 Million USD | -6247.307% |
| Clene Inc. | 32.16 Million USD | -339.719% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -80685.819% |
| BeyondSpring Inc. | 3.99 Million USD | -3439.875% |
| Synlogic, Inc. | 17.27 Million USD | -718.628% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -10778.308% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -403951.429% |
| Peak Bio, Inc. | 10.72 Million USD | -1218.975% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -172.361% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1647.196% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 20.11% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1903.939% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -103431.634% |
| MannKind Corporation | 382.37 Million USD | 63.016% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1216.986% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -34476.528% |
| Gossamer Bio, Inc. | 212.46 Million USD | 33.439% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -81174.713% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1443.696% |
| Legend Biotech Corporation | 328.67 Million USD | 56.973% |
| Mural Oncology plc | 15 Million USD | -842.221% |
| Disc Medicine, Inc. | 2.1 Million USD | -6630.985% |
| Champions Oncology, Inc. | 7.43 Million USD | -1803.338% |
| REGENXBIO Inc. | 89.29 Million USD | -58.381% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -16445.981% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -25473.708% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -2512.08% |
| Vaxart, Inc. | 26.51 Million USD | -433.371% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -803.205% |
| Cellectis S.A. | 92.85 Million USD | -52.303% |
| Longeveron Inc. | 2.04 Million USD | -6828.858% |
| Repare Therapeutics Inc. | 3.41 Million USD | -4047.155% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 89.876% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -203.524% |
| Revolution Medicines, Inc. | 87.94 Million USD | -60.805% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -81644.509% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -3477.485% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -44511.356% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -80710.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 82.506% |
| Denali Therapeutics Inc. | 52.24 Million USD | -170.703% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -881.697% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -10192.431% |
| Cingulate Inc. | 3.13 Million USD | -4410.799% |
| Passage Bio, Inc. | 26.29 Million USD | -437.834% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2021.8% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -34561.275% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -15718.568% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -587.797% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -5669.523% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -4428.274% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -17337.485% |
| OmniAb, Inc. | 25.56 Million USD | -453.257% |
| Anew Medical, Inc. | 1.6 Million USD | -8711.09% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -378.04% |
| Lipocine Inc. | 17.16 Thousand USD | -823726.168% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1115.14% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -308.392% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2294.051% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -147.351% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -69564.039% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -2638.006% |
| Ocugen, Inc. | 6.94 Million USD | -1937.43% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -900.906% |
| Q32 Bio Inc. | 1.31 Million USD | -10629.742% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -20944.345% |
| Alumis Inc. Common Stock | 32.58 Million USD | -334.064% |
| Equillium, Inc. | 824 Thousand USD | -17062.379% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1457.639% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -46913.025% |
| Dominari Holdings Inc. | 3.02 Million USD | -4570.343% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -149569.267% |
| vTv Therapeutics Inc. | 529 Thousand USD | -26633.081% |
| Bio-Techne Corporation | 419.53 Million USD | 66.292% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -96.425% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 26.941% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -737.387% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -521.29% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -2234.401% |
| Nkarta, Inc. | 88.33 Million USD | -60.086% |
| BioCardia, Inc. | 1.31 Million USD | -10654.221% |
| Iterum Therapeutics plc | 19.5 Million USD | -624.886% |